Crossmark

Is the Substitution of Cisplatin and 5-Flurouracil with Carboplatin and Capecitabine in the Treatment of Locally Advanced Head Neck Cancers (HNC) an Option? A Retrospective Single Center Analysis

Crossref DOI link: https://doi.org/10.1007/s44411-025-00050-7

Published Online: 2025-02-24

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mireștean, Camil Ciprian

Iancu, Roxana Irina

Iancu, Dragoș Petru Teodor

Stan, Mihai Cosmin

Bădulescu, Florinel
License Information

Text and Data Mining valid from 2025-02-24

Version of Record valid from 2025-02-24
More Information

Article History

Received: 2 February 2024

Accepted: 1 July 2024

First Online: 24 February 2025

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: The study protocol was evaluated and approved by the Ethics Committee of the University of Medicine and Pharmacy in Craiova, with approvals registration number 39/20.01.2023 and number 125/15.06.2023.

: Not aplicable.

Document is current

Any future updates will be listed below